相关实验视频
Updated: Jun 20, 2025

08:43
Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
67.2K
在摩洛哥人口中,ANCA和ASCA的个人资料具有炎症性肠病
Ouadii Abakarim1, Raymond Klevor1, Lahcen El Moumou2
1Faculty of Medicine and Pharmacy of Marrakesh, Cadi Ayyad University, Marrakesh, Morocco.
概括
对抗中性人细胞质抗体 (ANCA) 和抗Saccharomyces cerevisiae抗体 (ASCA) 的非侵入性抗体测试有助于诊断炎症性肠病 (IBD). 这些标记物有助于在摩洛哥患者中区分克罗恩病 (CD) 和性结肠炎 (UC).
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 临床诊断 临床诊断 临床诊断
背景情况:
- 炎症性肠病 (IBD) 诊断,特别是区分克罗恩病 (CD) 和性结肠炎 (UC),通常需要侵入性手术.
- 非侵入性血清标记物,包括抗中性粒细胞体抗体 (ANCA) 和抗Saccharomyces cerevisiae抗体 (ASCA),正在成为有价值的诊断工具.
研究的目的:
- 评估摩洛哥IBD人口中ANCA和ASCA抗体的频率.
- 评估ANCA和ASCA在这种特定的人口群体中对CD和UC的表征中的作用.
主要方法:
- 在2014年至2018年期间,马拉喀什的穆罕默德六世大学医院进行了一项横截面研究.
- 对p-ANCA,c-ANCA和ASCA进行了免疫学研究,使用60名IBD患者的免疫光和免疫剂测定.
主要成果:
- 这项研究包括60名参与者,20至30岁的年龄组受影响最大. 慢性病和UC分别在46.67%和45%的患者中被诊断出.
- 观察到不同的抗体概况:ANCA+/ASCA-在UC中更常见 (41%),而ANCA-/ASCA+仅用于CD (50%).
- ANCA阳性与UC有显著的相关性,而ASCA阳性与CD相关 (p <0.05).
结论:
- 摩洛哥人口中的IBD表现出独特的人口和表型特征.
- ANCA和ASCA抗体测试为IBD诊断和表征提供了一个有价值的,非侵入性的替代方案.
- 这些血清学标志物为IBD患者提供了个性化的管理策略和量身定制的治疗方法.
更多相关视频
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
331
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
331
Inflammatory Bowel Disease II: Crohn's Disease
208
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
208
Chronic Bowel Disorders: Introduction
436
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
436
Inflammatory Bowel Disease I: Ulcerative Colitis
160
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
160
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
154
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
154
Drugs for Treatment of Ulcerative Colitis in IBD
134
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
134

